American brain bank creates new hope for drug development at Lundbeck

Lundbeck is just one of many companies who have invested in the US-based Lieber Institute's brain bank. The industry hopes that the research done there can help to find new ways to tackle psychiatric disorders.

The US-based Lieber Institute has more than 3000 brains, and the hope is that the genetic information from them can help to generate the knowledge needed to achieve the next breakthrough within psychiatric disorders. Photo: Rune Pedersen/Ritzau Scanpix

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles